The Gates Cambridge Scholarship programme was established through a US$210 million donation to the University of Cambridge from the then Bill & Melinda Gates Foundation in 2000.
Since the first class in 2001, Gates Cambridge has awarded 2,218 scholarships to scholars from 112 countries who represent nearly 800 universities globally (more than 200 in the USA) and around 90 academic departments and all 31 Colleges at Cambridge.
Current scholars
Olivia RoweUnited States 2024 PhD MedicineDivision of Anaesthesia Research interest: use novel biomarkers to improve prognostic models of TBI and to narrow the research-to-practice gap in neurorehabilitation Section: PaCE |
Jonathan BleaselAustralia
2023 PhD MedicineResearch interest: utilise next generation sequencing to study patterns of gene expression in circulating immune cells before and after kidney transplantation and correlate this data with relevant clinical events |
Eckart De BieNetherlands
2023 PhD MedicineResearch interest: identify the mechanisms mediating the link between autoimmunity and PAH as well as biomarkers associated with autoimmunity in Pulmonary Arterial Hypertension (PAH) Section: HLRI (Mark Toshner) & CITIID (Chris Wallace) |
Ayden CaseUnited States
2022 PhD MedicineResearch interest: promising immunotherapy for atherosclerosis against the disparate impact of heart disease on racial and ethnic minority groups within both the US and UK Section: HLRI |
Kimia KamelianCanada, Islamic Republic of Iran
2022 PhD Medicine (Science)Research interest: expand on the utility of viral sequencing, either for diagnostics and guiding of prescribed regimens or for surveillance purposes, and contribute to communities that are not extensively studied or studied prospectively to reduce health disparities Recent publications: Prioritise vaccine boosters for vulnerable immunocompromised patients, say scientists | University of Cambridge Section: CITIID |
Tristan VornbäumenGermany
2022 PhD Infection and ImmunityResearch interest: mechanisms and new genetic factors that can be explored for therapeutic intervention of T cell-driven pathologies Section: CITIID |
Mahlaqua NoorPakistan
2019 PhD MedicineResearch interest: human cytomegalovirus (HCMV) and its interactions with the host immune system Recent achievement: 2nd in UK Falling Walls Lab for her compelling pitch Breaking the wall of the unshakable virus Section: CITIID |
